☰

Yen-Ling Chiu, Ph.D. - Publications

Affiliations: 
2013 Johns Hopkins University, Baltimore, MD 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Sung BY, Lin YH, Kong Q, Shah PD, Glick Bieler J, Palmer S, Weinhold KJ, Chang HR, Huang H, Avery RK, Schneck J, Chiu YL. Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. The Journal of Clinical Investigation. 132. PMID 35040433 DOI: 10.1172/JCI140508  0.578
2020 Wu CS, Chyuan IT, Chiu YL, Chen WL, Shen CY, Hsu PN. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection. Rheumatology (Oxford, England). PMID 32306043 DOI: 10.1093/Rheumatology/Keaa143  0.388
2020 Yang FJ, Hsieh CY, Shu KH, Chen IY, Pan SY, Chuang YF, Chiu YL, Yang WS. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease. Scientific Reports. 10: 5988. PMID 32249825 DOI: 10.1038/S41598-020-62989-7  0.35
2019 Yang TO, Chuang YF, Chiu YL. Correction to: T-cell aging in end-stage renal disease: an evolving story with CMV. Medical Microbiology and Immunology. PMID 31179524 DOI: 10.1007/S00430-019-00620-X  0.341
2019 Yang TY, Chuang YF, Chiu YL. T-cell aging in end-stage renal disease: an evolving story with CMV. Medical Microbiology and Immunology. PMID 30903371 DOI: 10.1007/S00430-019-00596-8  0.432
2018 Yang FJ, Shu KH, Chen HY, Chen IY, Lay FY, Chuang YF, Wu CS, Tsai WC, Peng YS, Hsu SP, Chiang CK, Wang G, Chiu YL. Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease. Immunity & Ageing : I & A. 15: 15. PMID 29988679 DOI: 10.1186/S12979-018-0120-0  0.373
2016 Shu KH, Chiang WC, Chiu YL. Anti-CD20 therapy and pauci-immune crescentic glomerulonephritis. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26786252 DOI: 10.1016/J.Jfma.2015.12.003  0.345
2016 Chiu YL, Lin CH, Sung BY, Chuang YF, Schneck JP, Kern F, Pawelec G, Wang GC. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size. Scientific Reports. 6: 19227. PMID 26778409 DOI: 10.1038/Srep19227  0.563
2015 Perica K, Bieler JG, Schütz C, Varela JC, Douglass J, Skora A, Chiu YL, Oelke M, Kinzler K, Zhou S, Vogelstein B, Schneck JP. Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy. Acs Nano. 9: 6861-71. PMID 26171764 DOI: 10.1021/Acsnano.5B02829  0.556
2014 Chiu YL, Shan L, Huang H, Haupt C, Bessell C, Canaday DH, Zhang H, Ho YC, Powell JD, Oelke M, Margolick JB, Blankson JN, Griffin DE, Schneck JP. Sprouty-2 regulates HIV-specific T cell polyfunctionality. The Journal of Clinical Investigation. 124: 198-208. PMID 24292711 DOI: 10.1172/Jci70510  0.573
2014 Perica K, De León Medero A, Durai M, Chiu YL, Bieler JG, Sibener L, Niemöller M, Assenmacher M, Richter A, Edidin M, Oelke M, Schneck J. Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 119-29. PMID 23891987 DOI: 10.1016/J.Nano.2013.06.015  0.559
2014 Chiu Y, Sung B, Bessell C, Oelke M, Schneck J. Wnt pathway activation functionally reprograms human antigen-specific T cells Journal For Immunotherapy of Cancer. 2: P4. DOI: 10.1186/2051-1426-2-S3-P4  0.597
2014 Chiu YL, Shan L, Huang H, Haupt C, Bessell C, Canaday DH, Zhang H, Ho YC, Powell JD, Oelke M, Margolick JB, Blankson JN, Griffin DE, Schneck JP. Sprouty-2 regulates HIV-specific T cell polyfunctionality Journal of Clinical Investigation. 124: 198-208. DOI: 10.1172/JCI70510  0.526
2011 Chiu YL, Schneck JP, Oelke M. HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL. Journal of Visualized Experiments : Jove. PMID 21505415 DOI: 10.3791/2801  0.544
2010 Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 56: 720-7. PMID 20801568 DOI: 10.1053/J.Ajkd.2010.06.015  0.306
2008 Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron. Clinical Practice. 109: c109-18. PMID 18663322 DOI: 10.1159/000145453  0.301
Show low-probability matches.